Adipokines and endothelial dysfunction in acute myocardial infarction and the risk of recurrent cardiovascular events

Journal of Cardiovascular Medicine

Volumn 16, Issue 1, 2015, Pages 37-44

  Grzywocz, Patryk ^a   Mizia Stec, Katarzyna ^b   Wybraniec, Maciej ^b   Chudek, Jerzy ^b  

^a 2nd Department of Cardiology   (Czech Republic)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Adipokines; Adiponectin; Apelin; Coronary artery disease; Resistin; Visfatin

Indexed keywords

ADIPONECTIN; APELIN; C REACTIVE PROTEIN; GLUCOSE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; ADIPOCYTOKINE; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CARDIOVASCULAR STENT; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; EVALUATION STUDY; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULSE WAVE; RECURRENT DISEASE; STABLE ANGINA PECTORIS; AGED; ATHEROSCLEROSIS; BLOOD; COMPARATIVE STUDY; COMPLICATION; INFLAMMATION; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; RISK ASSESSMENT; VASCULAR ENDOTHELIUM;

ADIPOKINES; AGED; ANGINA, STABLE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOSE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT;

EID: 84918815948     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. MacDougald OA, Hwang CS, Fan H, Lane MD. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci USA 1995; 92:9034-9037.
2. McTernan PG, McTernan CL, Chetty R, et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002; 87:2407.
3. Conde J, Scotece M, Gómez R, et al. Adipokines: bio factors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Bio factors 2011; 37:413-420.
4. Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 2005; 54:534-539.
5. Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010; 2010:535918.
6. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med 2008; 14:741-751.
7. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 2005; 288:H2031-H2041.
8. Kizer JR, Benkeser D, Arnold AM, et al. Associations of total and high molecular- weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study. Circulation 2012; 126:2951-2961.
9. Weir RA, Chong KS, Dalzell JR, Petrie CJ. Plasma apelin concentration is depressed following acute myocardial infarction in man. Eur J Heart Fail 2009; 11:551-558.
10. Guzik TJ, Mangalat D, Korbut R. Adipocytokines: novel link between inflammation and vascular function? J Physiol Pharmacol 2006; 57:505- 528.
11. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96:939-949.
12. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004; 27:2450-2457.
13. Kojima S, Funahashi T, Sakamoto T, Miyamoto S, Soejima H. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 2003; 89:667.
14. Krasnode bski P, Opolski G, Karnafel W. Plasma adiponectin levels in acute myocardial infarction and during the post infarction recovery period in patients with type 2 diabetes mellitus. Kardiol Pol 2011; 69:924-930.
15. Hui X, Lam KS, Vanhoutte PM, Xu A. Adiponectin and cardiovascular health: An update. Br J Pharmacol 2012; 165:574-590.
16. Korah TE, Ibrahim HH, Badr EA, ElShafie MK. Serum resistin in acute myocardial infarction patients with and without diabetes mellitus. Post grad Med J 2011; 87:463-467.
17. Krecki R, Krzemińska-Pakuła M, Peruga JZ, et al. Influence of treatment strategy on serum adiponectin, resistin and angiogenin concentrations in patients with stable multi vessel coronary artery disease after one-year follow-up. Kardiol Pol 2010; 68:1313-1320.
18. Vallejo S, Romacho T, Angulo J, et al. Visfatin impairs endothelium-dependent relaxation in rat and human mesenteric microvessels through nicotinamide phosphoribosyl transferase activity. PLoS One 2011; 6:e27299.
19. Losano GA. On the cardiovascular activity of apelin. Cardiovasc Res 2005; 65:8-9.
20. Chandrasekaran B, Dar O, McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail 2008; 10:725-732.
21. Strazyńska A, Bryl W, Hoffmann K, Pupek-Musialik D. Apelin in pathogenesis of cardiovascular diseases: Actual state of knowledge. Arterial Hypertens 2009; 13:417-421.
22. Li Z, Bai Y, Hu J. Reduced apelin levels in stable angina. Intern Med 2008; 47:1951-1955.
23. Kadoglou NP, Lampropoulos S, Kapelouzou A. Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease: KOZANI study. Transl Res 2010; 155:238-246.
24. Kreçki R, Krzemińska-Pakuła M, Peruga JZ, Szczes̈niak P. Elevated resistin opposed to adiponectin or angiogenin plasma levels as a strong, independent predictive factor for the occurrence of major adverse cardiac and cerebrovascular events in patients with stable multi vessel coronary artery disease over 1-year follow-up. Med Sci Monit 2011; 17:26-32.
25. Momiyama Y, Ohmori R, Uto-Kondo H, et al. Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention. J Atheroscler Thromb 2011; 18:108-114.
26. Persson J, Lindberg K, Gustafsson TP, Eriksson P, Paulsson-Berne G, Lundman P. Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. J Intern Med 2010; 268:194-205.
27. Huang SS, Huang PH, Chen YH, Chiang KH, Chen JW, Lin SJ. Association of adiponectin with future cardiovascular events in patients after acute myocardial infarction. J Atheroscler Thromb 2010; 17:295-303.
28. Hasan-Ali H, Abd El-Mottaleb NA, Hamed HB, Abd-Elsayed A. Serum adiponectin and leptin as predictors of the presence and degree of coronary atherosclerosis. Coron Artery Dis 2011; 22:264-269.